Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels

Journal of Internal Medicine

Volumn 274, Issue 2, 2013, Pages 163-175

  Abbenhardt, C ^a,b   Mctiernan, A ^b,c,d   Alfano, C M ^e   Wener, M H ^d   Campbell, K L ^f   Duggan, C ^b   Foster Schubert, K E ^c   Kong, A ^b,g   Toriola, A T ^a,h   Potter, J D ^b,d,i   Mason, C ^b   Xiao, L ^b   Blackburn, G L ^j   Bain, C ^b   Ulrich, C M ^a,b,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h USA   (United States)

ⁱ MASSEY UNIVERSITY   (New Zealand)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Adiponectin; Diet and exercise intervention; Leptin; Randomized controlled trial

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; AEROBIC EXERCISE; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; WEIGHT REDUCTION;

ADIPONECTIN; DIET AND EXERCISE INTERVENTION; LEPTIN; RANDOMIZED CONTROLLED TRIAL;

ADIPONECTIN; AGED; BODY MASS INDEX; DIET, REDUCING; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVENTION STUDIES; LEPTIN; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTMENOPAUSE; REFERENCE VALUES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84880327949     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12062     Document Type: Article

References (47)

1. Ford ES, Bergmann MM, Kroger J, Schienkiewitz A, Weikert C, Boeing H. Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med 2009; 169: 1355-62.
2. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep 2002; 4: 448-53.
3. Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96.
4. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT et al. Which obesity index best explains prevalence differences in type 2 diabetes mellitus? Obesity (Silver Spring) 2007; 15: 1294-301.
5. WCRF. World Cancer Research Fund: Food Nutrition, Physical Activity, and the Prevention of Cancer: A global Perspective. Washington, DC, USA: AICR, 2007.
6. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008; 8: 205-11.
7. Huang Z, Willett WC, Colditz GA et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 1999; 150: 1316-24.
8. Harvie M, Howell A, Vierkant RA et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev, a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005; 14: 656-61.
9. Ryan AS, Nicklas BJ, Berman DM, Elahi D. Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women. Int J Obes Relat Metab Disord 2003; 27: 1066-71.
10. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-78.
11. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-80.
12. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002; 13: 51-9.
13. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004; 5: 153-65.
14. Forsblom C, Thomas MC, Moran J et al. Serum adiponectin concentration is a positive predictor of all-cause and cardiovascular mortality in type 1 diabetes. J Intern Med 2011; 270: 346-55.
15. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 2005; 257: 167-75.
16. Gautron L, Elmquist JK. Sixteen years and counting: an update on leptin in energy balance. J Clin Investig 2011; 121: 2087-93.
17. Harwood HJ Jr The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012; 63: 57-75.
18. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-70.
19. Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B. Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab 2000; 2: 323-5.
20. Vendrell J, Broch M, Vilarrasa N et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962-71.
21. Okamoto Y, Kihara S, Funahashi T, Matsuzawa Y, Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006; 110: 267-78.
22. Friedenreich CM, Neilson HK, Woolcott CG et al. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer 2011; 18: 357-69.
23. Foster-Schubert KE, Alfano CM, Duggan CR et al. Effect of Diet and Exercise, Alone or Combined, on Weight and Body Composition in Overweight-to-Obese Postmenopausal Women. Obesity (Silver Spring) 2011; 20: 1628-38.
24. Mason C, Foster-Schubert KE, Imayama I et al. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med 2011; 41: 366-75.
25. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
26. Ryan DH, Espeland MA, Foster GD et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003; 24: 610-28.
27. World Health Organisation. BMI Classification. Geneva, Schwitzerland: Worl Health Organisation: WHO, 2009.
28. American Hearth Association. Metabolic Syndrom. Dallas, TX, USA: AHA, 2010.
29. Summer SS, Brehm BJ, Benoit SC, D'Alessio DA. Adiponectin changes in relation to the macronutrient composition of a weight-loss diet. Obesity (Silver Spring) 2011; 19: 2198-204.
30. Christiansen T, Paulsen SK, Bruun JM, Ploug T, Pedersen SB, Richelsen B. Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab 2010; 95: 911-9.
31. Drapeau S, Doucet E, Rabasa-Lhoret R, Brochu M, Prud'homme D, Imbeault P. Improvement in insulin sensitivity by weight loss does not affect hyperinsulinemia-mediated reduction in total and high molecular weight adiponectin: a MONET study. Appl Physiol Nutr Metab 2011; 36: 191-200.
32. Silva FM, de Almeida JC, Feoli AM. Effect of diet on adiponectin levels in blood. Nutr Rev 2011; 69: 599-612.
33. Simpson KA, Singh MAF. Effects of exercise on adiponectin: a systematic review. Obesity (Silver Spring) 2008; 16: 241-56.
34. Frank LL, Sorensen BE, Yasui Y et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005; 13: 615-25.
35. Mather KJ, Funahashi T, Matsuzawa Y et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 2008; 57: 980-6.
36. Drew JE. Molecular mechanisms linking adipokines to obesity-related colon cancer: focus on leptin. Proc Nutr Soc 2012; 71: 175-80.
37. Tworoger SS, Eliassen AH, Kelesidis T et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007; 92: 1510-6.
38. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005; 97: 1688-94.
39. Stattin P, Lukanova A, Biessy C et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer 2004; 109: 149-52.
40. Kelesidis I, Kelesidis T, Mantzoros C. Adiponectin and cancer: a systematic review. Br J Cancer 2006; 94: 1221-5.
41. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-5.
42. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010; 91: 258S-61S.
43. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 179-88.
44. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Investig 2006; 116: 1784-92.
45. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14: 741-51.
46. Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010; 152: 93-100.
47. Farooqi IS, Matarese G, Lord GM et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Investig 2002; 110: 1093-103.